Children’s Hospital Los Angeles has expanded its cell and gene therapy program to include 12 FDA-approved therapies.
The program now offers more cell and gene therapies than any pediatric center on the West Coast, according to a March 5 news release from the hospital.
The therapies treat neuromuscular disorders, blood disorders, cancer, inherited retinal disease, dermatologic and transplantation-associated conditions.
The hospital plans to launch a clinical trial to study a sickle cell gene therapy product, as well as a CAR T-cell therapy developed by investigators at Children’s Hospital Los Angeles for pediatric solid tumors, the release said.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
